Insiders / Valantine Hannah

Valantine Hannah

CIK 1855608personinsider

Companies

3

First seen

Mar 3, 2026

Last activity

Jun 16, 2026

Companies

Company	Role	Shares held	Peak held	Trades	Latest
CareDx, Inc. · CDNA	Director	36,686	48,789	2	—
BridgeBio Pharma, Inc. · BBIO	Director	7,465	32,949	7	—
Pacific Biosciences of California, Inc. · PACB	Director	—	223,492	1	—

All securities held

4 positions · latest reported per filing

Company	Security	Shares	As of
BridgeBio Pharma, Inc.	Common Stock	7,465	Mar 10, 2026
BridgeBio Pharma, Inc.	Stock Option (Right to Buy)Derivative	17,343	Mar 10, 2026
CareDx, Inc.	Common Stock	36,686	Jun 15, 2026
Pacific Biosciences of California, Inc.	Stock Option (right to buy)Derivative	223,492	Jun 3, 2026

Activity

InsidersInstitutions

This person's insider trades (Form 4), across every company.

Date	Action	Company	Value	Shares Δ	Position after	Impact
Feb 27, 2026	Exercise	BBIO BridgeBio Pharma, Inc. Common Stock	$1.23M	+25K +341.38%	32,949 0.02% of shares	low
Feb 27, 2026	Sell	BBIO BridgeBio Pharma, Inc. Common Stock	$978.3K	-15K -44.26%	18,365 <0.01% of shares	medium
Feb 27, 2026	Sell	BBIO BridgeBio Pharma, Inc. Common Stock	$739.5K	-11K -59.35%	7,465 <0.01% of shares	medium
Mar 10, 2026	Sell	BBIO BridgeBio Pharma, Inc. Common Stock	$624.3K	-9K -53.74%	7,465 <0.01% of shares	medium
Jun 15, 2026	Sell	CDNA CareDx, Inc. Common Stock	$279.7K	-12K -24.81%	36,686 0.07% of shares	medium
Mar 10, 2026	Exercise	BBIO BridgeBio Pharma, Inc. Common Stock	$237.2K	+9K +116.16%	16,136 <0.01% of shares	low
Jun 12, 2026	Grant	CDNA CareDx, Inc. Common Stock	$0	+10K +25.12%	48,789 0.09% of shares	low
Jun 3, 2026	Grant	PACB Pacific Biosciences of California, Inc. Stock Option (right to buy)	—	+223K	223,492 0.07% of shares	low
Mar 10, 2026	Exercise	BBIO BridgeBio Pharma, Inc. Stock Option (Right to Buy)	—	-9K -33.33%	17,343 <0.01% of shares	low
Feb 27, 2026	Exercise	BBIO BridgeBio Pharma, Inc. Stock Option (Right to Buy)	—	-25K -100.00%	0 0.00% of shares	low